ProBio's CDMO Services for Investigator Initiated Trials (IIT)

In the advanced therapies space, China-based investigator-initiated trials (IIT) present a smart approach to accessing early first in human clinical trial data.

Generate early human data ahead of IND and Phase I trials
Quickly assess preliminary safety and efficacy
Rapidly screen multiple candidates
Reduce operational cost
Increase investor confidence
Strengthen partnership position for licensing out your discovery

ProBio scientists use the same vectors, hosts, and analytics alongside processes and QC developed at the earliest stage to meet global regulatory expectations. Seamless execution. Regulatory confidence. From IIT in China to IND anywhere in the world and on to global filing, ProBio delivers seamless execution and assures regulatory compliance, translating your early discovery into a global opportunity.
Learn more at: https://www.probiocdmo.com

00:00